Xanodyne Pharmaceuticals Report issue

Contributed to NME For profit Phase 3 Phase 4
Founded: Newport KY United States (2000)
Status: Acquired by Assertio (2012)

Organization Overview

First Clinical Trial
2006
NCT00366444
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Xanodyne | XANODYNE PHARM | XANODYNE PHARMS INC